Multivalent VLA-4 antagonists comprising polymer moieties

Details for Australian Patent Application No. 2005265316 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Konradi, Andrei W.; Yednock, Theodore; Pleiss, Michael A.; Semko, Christopher M.; Smith, Jenifer L.

Agent Freehills

Pub. Number AU-B-2005265316

PCT Pub. Number WO2006/010054

Priority 60/586,975 08.07.04 US

Filing date 8 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 2 February 2012

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/010054 Priority application(s): WO2006/010054

2 February 2012 Application Accepted

  Published as AU-B-2005265316

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265319-Therapeutic peptides

2005265311-Soy compositions having improved organoleptic properties and methods of generation